Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid

A technology of hydroxynicotinamide and ethyl hydroxyphenylacetate is applied in the synthesis field of pharmaceutical intermediates, can solve the problems of high equipment and operation requirements, harsh reaction conditions, long synthesis routes, etc., and achieves easy control of process parameters. , the effect of strong quality and cost, high product yield

Active Publication Date: 2010-11-10
QILU ANTIBIOTICS PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The structure of the compound is complex, the synthetic route is long, and the reaction conditions are harsh, thereby restricting the production of cefpiramide bulk drug
Patent JP54-030197 introduces a synthetic method of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid (I) in the form of a reference example, but because its intermediates need to pass through Dry hydrogen chloride gas is made into hydrochloride, which requires high equipment and operation, which is not conducive to large-scale industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid
  • Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid
  • Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for synthesizing an intermediate of cephalosporins antibiotics cefpiramide, D-alpha-(6-methyl-4-hydroxy nicotinamido)-p-hydroxyphenyl acetic acid. The method comprises the steps of: reacting carboxyl group protected D-p-hydroxyphenyl glycine and anhydride or acyl chloride of 4-hydroxy-6-methylnicotinic acid to obtain acylated product, and hydrolyzing to remove the protecting group to obtain the target product D-alpha-(6-methyl-4-hydroxy nicotinamido)-p-hydroxyphenyl acetic acid. The method has the advantages of easy and feasible operation, and applicability to large scale production.

Description

Synthesis of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid technical field The invention relates to a synthesis method of D-α-(6-methyl-4-hydroxynicotinamide) p-hydroxyphenylacetic acid, an acid intermediate at the 7-position of cefpiramide, a cephalosporin antibiotic, and belongs to the technical field of synthesis of pharmaceutical intermediates . Background technique The chemical name of cefpiramide (cefpiramide) is (6R, 7R)-7-[(R)-2-(4-hydroxy-6-methyl-3-pyridinecarbonylamino)-2-(p-hydroxyphenyl)acetyl Amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4,2,0] Oct-2-ene-2-carboxylic acid. Its structural formula is: Cefpiramide is a third-generation cephalosporin antibiotic jointly developed by Sumitomo Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. It was first listed in Japan in 1985 and has been included in the American, Japanese, British and European Pharmacopoeias. It is characterized by broad anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D213/82
CPCY02P20/55
Inventor 赵振华董付敏王勇进
Owner QILU ANTIBIOTICS PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com